674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck cancer patients

Autor:	Faye Johnson, Nashat Gabrail, Ammar Sukari, Barbara Burtness, Christine H Chung, Sara Pai, Lara A Dunn, Cristina Rodriguez, Marya Chaney, Apollina Goel, Ricklie Julian, Francis Worden, Rami Haddad, Douglas Adkins, A Dimitrios Colevas, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, Jong Chul Park, Robert M Jotte, Tanguy Y Seiwert, Nabil F Saba, Julie E Bauman, Michael K Gibson
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Druh dokumentu:	article
ISSN:	2051-1426
DOI:	10.1136/jitc-2023-SITC2023.0674
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/f019dc6fe3184b2e98dc1f578cff46b0 Zobrazit plný text záznamu View record in DOAJ